Zydus Lifesci.

{
  "main_header": {
    "sid": 290229,
    "name": "Zydus Lifesci.",
    "stock_name": "Zydus Lifesci.",
    "full_name": "Zydus Lifesciences Ltd",
    "name_url": "stocks-analysis/zydus-lifesci",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,101.40",
    "chg": 2.1,
    "chgp": "0.19%",
    "dir": 1,
    "prev_price": "1,099.30",
    "mcapval": "110,817.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532321,
    "symbol": "ZYDUSLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE010B01027",
    "curr_date": "Jun 25, 03:30 PM",
    "curr_time": "16:10 PM",
    "last_traded_at": "Jun 25, 03:30 PM IST",
    "bse_nse_vol": "12.28 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 25, 2026",
    "traded_date_str": "2026 06 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zydus-lifesci-290229-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zydus-lifesci-290229-1&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Signalling Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-signalling-bullish-market-positioning-4073544",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZydusLifescienc_oi_spurts_by_underlying_4073544.png",
        "date": "2026-06-25 15:00:18",
        "description": "Zydus Lifesciences Ltd has witnessed a notable surge in open interest (OI) in its derivatives segment, with an 11.32% increase to 23,835 contracts from 21,411 previously. This rise, coupled with robust volume and price action near its 52-week high, suggests growing bullish sentiment and strategic positioning by market participants in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Zydus Lifesciences Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-significant-open-interest-surge-amid-mixed-market-signals-4070688",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZydusLifescienc_oi_spurts_by_underlying_4070688.png",
        "date": "2026-06-24 15:00:17",
        "description": "Zydus Lifesciences Ltd has witnessed a notable 12.7% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight dip in the stock price, the surge in open interest alongside robust volume patterns suggests evolving directional bets within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Zydus Lifesciences Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-significant-open-interest-surge-amid-mixed-market-signals-4070619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZydusLifescienc_oi_spurts_by_underlying_4070619.png",
        "date": "2026-06-24 14:00:15",
        "description": "Zydus Lifesciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.6% surge in open interest in its derivatives segment, signalling heightened market activity despite a modest price decline. This development comes alongside a fresh 52-week high and increased investor participation, reflecting a complex interplay of bullish and cautious positioning among traders."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Zydus Lifesciences Ltd to 52-Week High of Rs 1126.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-hits-new-52-week-high-at-rs112625-4069976",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZydusLifescienc_priceRelatedfactors_4069976.png",
        "date": "2026-06-24 09:42:38",
        "description": "With a decisive breakout to Rs 1126.25 on 24 Jun 2026, Zydus Lifesciences Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Zydus Lifesciences Ltd to 52-Week High of Rs 1124.1",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-hits-new-52-week-high-at-rs11241-4069136",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZydusLifescienc_priceRelatedfactors_4069136.png",
        "date": "2026-06-23 11:35:11",
        "description": "With a decisive surge to Rs 1124.1 on 23 Jun 2026, Zydus Lifesciences Ltd has reached a fresh 52-week high, reflecting a strong alignment of technical indicators and sustained price momentum that has propelled the stock well above its 52-week low of Rs 835.85."
      },
      {
        "title": "Zydus Lifesciences Ltd Upgraded to Strong Buy on Robust Fundamentals and Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-lifesciences-ltd-upgraded-to-strong-buy-on-robust-fundamentals-and-technicals-4068388",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZydusLifescienc_mojoScore_4068388.png",
        "date": "2026-06-23 08:32:53",
        "description": "Zydus Lifesciences Ltd has been upgraded from a Buy to a Strong Buy rating, reflecting significant improvements across technical indicators, valuation metrics, financial trends, and overall quality. This upgrade, effective from 22 June 2026, underscores the company’s resilient fundamentals and bullish market signals amid a challenging pharmaceutical sector backdrop."
      },
      {
        "title": "Zydus Lifesciences Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4067956",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZydusLifescienc_technicaldot_4067956.png",
        "date": "2026-06-23 08:01:49",
        "description": "Zydus Lifesciences Ltd has demonstrated a notable shift in technical momentum, upgrading from a mildly bullish to a bullish trend as of late June 2026. The stock’s recent price action, supported by key technical indicators such as MACD, RSI, and moving averages, signals growing investor confidence in this mid-cap pharmaceutical player amid a broader sector recovery."
      },
      {
        "title": "Zydus Lifesciences Declines 3.03% Amid Mixed Technical Signals and Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-declines-303-amid-mixed-technical-signals-and-downgrade-4066223",
        "imagepath": "",
        "date": "2026-06-21 11:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> Stock opens at Rs.1,087.75, declines 1.50%</p>\n                    <p><strong>16 Jun:</strong> Further dip to Rs.1,078.40 (-0.86%) amid sideways market</p>\n                    <p><strong>17 Jun:</strong> Sharp fall to Rs.1,061.50 (-1.57%) coinciding with technical downgrade</p>\n                    <p><strong>18 Jun:</strong> Slight recovery to Rs.1,074.30 (+1.21%) after downgrade announcement</p>\n                    <p><strong>19 Jun:</strong> Week closes at Rs.1,070.90 (-0.32%) with subdued volume</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-v..."
      },
      {
        "title": "Zydus Lifesciences Ltd Downgraded to 'Buy' by MarketsMOJO Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-lifesciences-ltd-downgraded-to-buy-by-marketsmojo-amid-mixed-technical-signals-4060563",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZydusLifescienc_mojoScore_4060563.png",
        "date": "2026-06-18 08:18:12",
        "description": "Zydus Lifesciences Ltd has seen its investment rating downgraded from Strong Buy to Buy as of 17 June 2026, reflecting a nuanced shift in its technical outlook and financial performance. Despite robust long-term fundamentals and market-beating returns, recent technical indicators and flat quarterly results have tempered enthusiasm among analysts, prompting a recalibration of the stock’s overall mojo grade to 72.0."
      }
    ],
    "total": 697,
    "sid": "290229",
    "stock_news_url": "https://www.marketsmojo.com/news/zydus-lifesciences-290229"
  },
  "announcements": [
    {
      "details": "Cadila Healthcare Limited has informed the Exchange regarding Disclosure of Consolidated Related Party Transactions for the half year ended on September 30, 2019.",
      "source": "NSE",
      "caption": "Cadila Healthcare Limited - Other General Purpose",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 05, 2019, titled \"Zydus announces regulatory filing of Saroglitazar Magnesium for treatment of NASH with DCGI\".",
      "source": "NSE",
      "caption": "Cadila Healthcare Limited - Press Release",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 03, 2019, titled \"Zydus receives tentative approval from the USFDA for Lorcaserin Hydrochloride Tablets\".",
      "source": "NSE",
      "caption": "Cadila Healthcare Limited - Press Release",
      "datetime": "03-Dec-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:5</strong> stock split, ex-date: 06 Oct 15",
          "dt": "2015-10-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 05 Apr 10",
          "dt": "2010-04-05",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Zydus Lifesciences Sees Sharp Open Interest Surge Signalling Bullish Market Positioning

2026-06-25 15:00:18

Zydus Lifesciences Ltd has witnessed a notable surge in open interest (OI) in its derivatives segment, with an 11.32% increase to 23,835 contracts from 21,411 previously. This rise, coupled with robust volume and price action near its 52-week high, suggests growing bullish sentiment and strategic positioning by market participants in the pharmaceuticals and biotechnology sector.

Read full news article

Zydus Lifesciences Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-06-24 15:00:17

Zydus Lifesciences Ltd has witnessed a notable 12.7% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight dip in the stock price, the surge in open interest alongside robust volume patterns suggests evolving directional bets within the Pharmaceuticals & Biotechnology sector.

Read full news article

Zydus Lifesciences Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-06-24 14:00:15

Zydus Lifesciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.6% surge in open interest in its derivatives segment, signalling heightened market activity despite a modest price decline. This development comes alongside a fresh 52-week high and increased investor participation, reflecting a complex interplay of bullish and cautious positioning among traders.

Read full news article

Broad-Based Technical Strength Lifts Zydus Lifesciences Ltd to 52-Week High of Rs 1126.25

2026-06-24 09:42:38

With a decisive breakout to Rs 1126.25 on 24 Jun 2026, Zydus Lifesciences Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions.

Read full news article

Broad-Based Technical Strength Lifts Zydus Lifesciences Ltd to 52-Week High of Rs 1124.1

2026-06-23 11:35:11

With a decisive surge to Rs 1124.1 on 23 Jun 2026, Zydus Lifesciences Ltd has reached a fresh 52-week high, reflecting a strong alignment of technical indicators and sustained price momentum that has propelled the stock well above its 52-week low of Rs 835.85.

Read full news article

Zydus Lifesciences Ltd Upgraded to Strong Buy on Robust Fundamentals and Technicals

2026-06-23 08:32:53

Zydus Lifesciences Ltd has been upgraded from a Buy to a Strong Buy rating, reflecting significant improvements across technical indicators, valuation metrics, financial trends, and overall quality. This upgrade, effective from 22 June 2026, underscores the company’s resilient fundamentals and bullish market signals amid a challenging pharmaceutical sector backdrop.

Read full news article

Zydus Lifesciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-23 08:01:49

Zydus Lifesciences Ltd has demonstrated a notable shift in technical momentum, upgrading from a mildly bullish to a bullish trend as of late June 2026. The stock’s recent price action, supported by key technical indicators such as MACD, RSI, and moving averages, signals growing investor confidence in this mid-cap pharmaceutical player amid a broader sector recovery.

Read full news article

Zydus Lifesciences Declines 3.03% Amid Mixed Technical Signals and Downgrade

2026-06-21 11:00:06

Key Events This Week

15 Jun: Stock opens at Rs.1,087.75, declines 1.50%

16 Jun: Further dip to Rs.1,078.40 (-0.86%) amid sideways market

17 Jun: Sharp fall to Rs.1,061.50 (-1.57%) coinciding with technical downgrade

18 Jun: Slight recovery to Rs.1,074.30 (+1.21%) after downgrade announcement

19 Jun: Week closes at Rs.1,070.90 (-0.32%) with subdued volume

Week Open

Read full news article

Zydus Lifesciences Ltd Downgraded to 'Buy' by MarketsMOJO Amid Mixed Technical Signals

2026-06-18 08:18:12

Zydus Lifesciences Ltd has seen its investment rating downgraded from Strong Buy to Buy as of 17 June 2026, reflecting a nuanced shift in its technical outlook and financial performance. Despite robust long-term fundamentals and market-beating returns, recent technical indicators and flat quarterly results have tempered enthusiasm among analysts, prompting a recalibration of the stock’s overall mojo grade to 72.0.

Read full news article

View All News